NRAS and non-Hodgkin lymphoma: When correlated with a history of non-Hodgkin lymphoma, expression of myeloid markers, complex karyotype, TP53 gene aberrancies, KRAS and NRAS mutations, and B-ALL associated translocations (Figure 5), all 13 cases were correctly classified.